Last reviewed · How we verify

NCT05976178: ADDICTALGO

Study of the Characteristics of Chronic Pain in Patients With Addiction

Completed Last updated 11 May 2025
What this trial tests

trial in Chronic Pain in 300 participants. Completed in 1 March 2025.

Timeline
10 December 2022
Primary endpoint
1 March 2025
1 March 2025

Quick facts

Lead sponsorGroupe Hospitalier de Bretagne Sud
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date10 December 2022
Primary completion1 March 2025
Estimated completion1 March 2025
Sites1 location across France

Conditions studied

Sponsor

Groupe Hospitalier de Bretagne Sud

Who can join

18 and older, any sex, with Chronic Pain or Addiction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is described in the literature a higher prevalence of pain in patients with an addiction but there are few studies describing the pain profile of patients with use disorder. Pain has a very negative impact on the quality of life of opioid substituted patients. Improving knowledge on this point would make it possible to better guide specific care. The investigator proposes to conduct a single-center descriptive observational study using questionnaires, without changing the management of patients with chronic pain. The primary objective of the study is to determine the prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Groupe Hospitalier de Bretagne Sud trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05976178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing